{"name":"Beijing Bio-Targeting Therapeutics Technology Co., Ltd","slug":"beijing-bio-targeting-therapeutics-technology-co-ltd","ticker":"","exchange":"","domain":"beijingbiotargetingtechnology.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"BioTTT001 injection","genericName":"BioTTT001 injection","slug":"biottt001-injection","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"BioTTT001 injection","genericName":"BioTTT001 injection","slug":"biottt001-injection","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi1AFBVV95cUxPMEhIU1hYWkZNdE5XZnFrbEZHc2pSTWhEWkNSMm9rS01VS256YVk1VElTa3lFLWZiVTN0Z1prMmE1RGZ2ZGRVcHNYSUlEMzkwUkt5WkRPdXd6N2VwdHdmM2RSZV9NMFhhWHktOVJDM1dUSENmX3I0SUs1b2RUcGZIcFA0SG5DQWhIVGxMaU9yajgtTWxTYkFJREYzR2VQNklva2NrY0lvNllfeksxSFQ3dm42OEdGN1VIcmR0Vy1JWFpfd1FlRU8wZW56VWJwaDFlbmt3Xw?oc=5","date":"2026-04-01","type":"deal","source":"Business Wire India","summary":"Biocytogen and Sihuan Pharmaceutical Announce Strategic Partnership in Weight Loss and Beyond - Business Wire India","headline":"Biocytogen and Sihuan Pharmaceutical Announce Strategic Partnership in Weight Loss and Beyond","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigJBVV95cUxNY0paTlREYU1FOW4tOC1DNlFLM0tjaWQwcXVmSEpPN1ZoSndCTlU2eXhpUXRlbnpQMjM4OEZfbmNybWVIdFhaeTIwdTNxV21xay0zQVFUMzNMUnFMU2ZmcjQ1RVRsNEljUTJkdnJBTFZwMGVBNTdmOTU1b3hTcGZnbXo5MjYxNkxTeGJWT2FUNjBZQ1lHZkIycFZIekFEVXp3Szk2ZVdSNTAyYzUtVFVVWk9PNGQ3TGxHRjdDaFA5N21obUZDV3VIVks2QVMyOXhXdVJZMjFTVk1ZZkZwdXpNeEZNcGJJanlvTmM1TlVVT0ZaRG9wVXlrdDV3cFRsem9kOE1yeVFXdXFNdw?oc=5","date":"2026-03-30","type":"deal","source":"Business Wire","summary":"Biocytogen Grants Taisho Pharmaceutical a License to its RenNano - Business Wire","headline":"Biocytogen Grants Taisho Pharmaceutical a License to its RenNano","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTE5NZkZlc3l0VTRHTkZIcEE1NGlUTDhHY2lnbGVtMzNSSGY2YVdpUnRYaFVPWnNGaE9BR1dsZkVCTS1Bb2lub3oyM1BIckNuRE0xbEZRLWNlSEpiamo2QXN0VEUtUGxkMWlBeDdmZw?oc=5","date":"2026-03-30","type":"pipeline","source":"Yahoo Finance Singapore","summary":"CANbridge Pharmaceuticals Inc. (1228.HK) Analyst insights, Price targets and Recommendations - Yahoo Finance Singapore","headline":"CANbridge Pharmaceuticals Inc. (1228.HK) Analyst insights, Price targets and Recommendations","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4gFBVV95cUxNX3ZBaktKZEg1dnRyN2R1d1pZdFEwSmROd0pqTHdYeG50Tk1pelMtQ1dtU3ktX09ZMzAwUERidWdsZVV4bXM0YWZ6c1N5RlZWRHlaTmYxRUt4bUlrQ01KOXFDZ3oxb3otOXhsaTEzXy1KUjJsZXJXVUE3MlF5aXZhQlVNTmxBemdRYmRMU3NSbFdSOUJ3X21TM0lMSW1MaVRqNi1lMlRYTzBLN2ctNXp6SVFKYlNHYWVOeEdYYk1mS3p6RVlOM1JxS0o3WU1hNUN5RnZaWG1LZ3hkMEM0dmVQbnV3?oc=5","date":"2026-03-26","type":"regulatory","source":"Business Wire","summary":"Biocytogen Announces FDA IND Clearance for Partner NEOK Bio’s NEOK002 Targeting Solid Tumors - Business Wire","headline":"Biocytogen Announces FDA IND Clearance for Partner NEOK Bio’s NEOK002 Targeting Solid Tumors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9AFBVV95cUxNX25uV3FLTER5cTluWVdxVW5BejE0T0NnSlEzV3Mza2hfd2VDZ1lPbEMzUnpaVDRGelhJdS1ENklWdGM4bEtMclNLemdEcGh0ZkNIM19JdldqaTRfX1pBR3NZMkFBZ29maXBnZHBVdlhySzRSallMbDJUZ2YyZ0l4Y1VNV28wN1JCa2hDSkV6bjhmRF81akhxWmVfd24tWE5XRFlFXzlZOVlieXhEVVRla0JaODZjZGEwNjlwTnZfakE4TUg3NTd4TEphWEt5ZTJZci14NEprdHZLYzB3Rk9QSGtsd2JwMHRCSWVHZzZGTG5MVS1L?oc=5","date":"2026-03-23","type":"deal","source":"Business Wire India","summary":"Biocytogen Announces Strategic Collaboration with Moonlight Bio to Advance Cell Therapies Using Library of Antibody Binders - Business Wire India","headline":"Biocytogen Announces Strategic Collaboration with Moonlight Bio to Advance Cell Therapies Using Library of Antibody Bind","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxQSDBXZ243SnRELU9tTG5VZTBBaUFIQkVwVmJEYW42OGc5emVxOWVhSGlZcng5U1RDZE5IWUM5YUdYRE1VSDBpVFZxTW5iNUF0X29DSUlDa3RBaHpKRmhwODNuU1hlRmEyQzNDLU9VUlVYN29vb3dTZFl1T21FU2FWNXpGZklzS2hZQXNoV21KczXSAZYBQVVfeXFMTmdVSG5xdU5Qa2JKdFpoQWYyaHhkUkxfM1FUdmljWjc5Z2VZYkxxRzhsa0VmZWZXc2h1UWY4MFFibXlwbXplT0VBS2dITk5ya1oxVlRwN3JJUF9fOFkwQlZ5eHB1NmNwRWZQV0NvMVlmSDZka3laZlZTMjNaN1FXdWxiU0hUSC1XckpWb09qRGNVSDI3UXdR?oc=5","date":"2026-01-17","type":"pipeline","source":"BioInformant","summary":"CAR-T Cell Companies Proliferate: List of CAR-T Companies Worldwide - BioInformant","headline":"CAR-T Cell Companies Proliferate: List of CAR-T Companies Worldwide","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0wFBVV95cUxPeDlIQzU0UjhtVDRiWlpCNkRudWRnQjdUeTJuenpud0xBTkdBZW4yWC1DaTgxOURVRmxXVDJLOGtKN05HSVlKQ2RTU0ZTUnp2dm9HOW9zeWYxNGx4cW9TSUlxNmJ3WjM5WG80NHhfRXhhZTk2QmRvMV9pREJkeFJKZU9vTW8zcmx3Q2ZWSHZ2OXFjSkRNUlNCTFR3R2gzMGFRbmF6NmZhVlRhQUx5OGpqNnM4a0xyRnFoNTVGck1NVjFlYzhUZTZjdWRJTUFEa3ozdWU0?oc=5","date":"2025-12-10","type":"pipeline","source":"Business Wire","summary":"Biocytogen Completes STAR Market IPO, Becoming the First “H+A” Global Drug Innovator - Business Wire","headline":"Biocytogen Completes STAR Market IPO, Becoming the First “H+A” Global Drug Innovator","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1wFBVV95cUxNTzFnMThZTTJKbG1vTjNOZnI0UmZTc0xtUVZudmJJLWtiRnRwcFVXSTNHZXMtQUJUM202UlltOXRNN1M0TkNpeS1GdkxzR0RMZ2JxVmZydkhBbGJVbXVxRFE0UTQwOXR1eUdRZUgtaXlkcW1rOEZKdGZhWmJLRTZyWHZSeHRqeTlBbTljc0lmXzc5TWlKbE9zTUVuS24zZXJOSDhWRHJudE1BNlRwd0ZrcFEtUWtKZkJlQk85RXg5Y1BxRW9Vcm44bzhLOUkzdXgxWUlZNDFrNA?oc=5","date":"2025-12-04","type":"regulatory","source":"Business Wire","summary":"IDE034, a Bispecific ADC Licensed by Biocytogen to IDEAYA, Receives FDA IND Clearance - Business Wire","headline":"IDE034, a Bispecific ADC Licensed by Biocytogen to IDEAYA, Receives FDA IND Clearance","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwJBVV95cUxQUnR4eWV5U1NYbGNCcFE2ckFpNU1CUkRVanR4ZUtxSTA3Q0ZRdlhWR2lENEhOTWdJTThLVDkzWU5RUkVsOVEzdGhIc3BVMzBYOUlFdi00bi1jaV9KampMakV5cjc5ZWVvZWwycW9kM1A2U21zNmNkYXBxOEZkRUxIR1dmRnhkX1dLTmFTTXlVV3puUjQtWVp4YjdXYVc1Zi0xTDNYODA3WFVzeDhwS3RydGt1cGprN2R4cVNob2FuMmsyazhTMUtuR1BMcGU3bVFlbmNrUFRNZ3Q3RC1mWmY5Y25YNnFIWENyV1dSYXVCODB1dzdNaXlVc1hLcDNUVUpxZGxwTURoV01aUk1PTVNvNXptTQ?oc=5","date":"2025-09-03","type":"pipeline","source":"Business Wire","summary":"Biocytogen Enters into Agreement with Merck, KGaA, Darmstadt, Germany to Advance Antibody-Conjugated Lipid-Based Delivery Solutions - Business Wire","headline":"Biocytogen Enters into Agreement with Merck, KGaA, Darmstadt, Germany to Advance Antibody-Conjugated Lipid-Based Deliver","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9gFBVV95cUxQQVlJS1ozd1d6LS1wN1lGLVh6Vklob2liZG5vSVF5b1NjM21MckoyU0c5a1JVWUdKc3RNNGJLTEdzYzFlR3A2elY2amdXbFhuVG42TEhDT2NHeHNwMm5lOWUzRFNJLWNZX3N2aUV3WFowa0kteFFpZ1dPd3RTc29nZFB5a3Jkd3BKdVdKdDNxQV8wSDVVZFR6NjBacm1DZ09ra3NLNUdmVjViT0laR3ctX1pZbVBVOUxCOF9QMTZoa3FaUUU1YW1rSXhIUWZzSXZyTEgtTktDSGRkbm5OWmkxRno3ZkwxWWRuM0JfNkJKVzJyMGFtdWc?oc=5","date":"2025-06-04","type":"regulatory","source":"BioSpace","summary":"Biocytogen and Nanjing Chia Tai Tianqing Announce IND Approval in China for Co-Developed Anti-IGF-1R Antibody NTB003 (BCG009) - BioSpace","headline":"Biocytogen and Nanjing Chia Tai Tianqing Announce IND Approval in China for Co-Developed Anti-IGF-1R Antibody NTB003 (BC","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMivgJBVV95cUxNVjBnQzhVR2J4bkRIWHhma1laN2RFazNfREhLZWZhUXA4MUFLQTBaWDlFaFdUamtCTTVpaXJxRzNUa0U2S1dxeTlXbnAtTUJ6elRMcGhyb3lPcnNlOUNvWldqQzFCWDdDNEhSQ2ZXQmpjQTNNREZ1bGxYNVhpbnBKUXlaMk5QZGxNSWE5TUZ1VWVtMFY2MUNjel9xSTZmTl9rMFBUTE9YNUl1bzVCRTkwZXVoZURfazBvdTFnQi12ZFg2aFFWclJMSGF4b3lIQ3FpajQ4ZnRqdi1CSTZzWTFSY3hvaXNodTUzeXExQV90c1c5T25Rc1o0b1ZKeTdpMjhfdVlEeU1IY3hHMXdqSEZhS2JiYlNsam5tMFRFZEtNaVJDNG5DOTBBZzJfbWxQRGJhd2dSV2ZsLTdXNHZMZGc?oc=5","date":"2024-11-11","type":"pipeline","source":"PR Newswire","summary":"IDEAYA Announces Development Candidate Nomination of IDE034, a Potential First-in-Class B7H3/PTK7 Topo-I-Payload Bispecific ADC and Option Exercise with Biocytogen - PR Newswire","headline":"IDEAYA Announces Development Candidate Nomination of IDE034, a Potential First-in-Class B7H3/PTK7 Topo-I-Payload Bispeci","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgJBVV95cUxNNFlKU09tYWVwRkQzXzdzNUZ3Ykl5V2hKcWFqVHdMWVpiYTBmeFhTU2xvSWhES1JuUjNGSGpQTWRWODlkc0NHbzNleDF5aEhZZ1czeHlrS0Q4NzFsZUt2cTlPN0xwXzRqT1RGVlYzOEpuV2dyOEdORTR2NzlBdE5zTXRLY0psVFFSNDA1YVYyWXRPX0EwS1NMT2NTdG5LamlEeFRBRnBfcjdKdmE4amlTU2l0VTVNZ1gyX29jc1M3THk0OUY0UHozak5vNUZHNUdhNlBoQ2xpcmsyLVRwRWhxVURFR1pjUWZUNnBrdEs3cm5EbjNHYnpZS2NaWE12eDZoMC1kaGtQbTZEZDZvcWxGR081VVd4c1ZzdEdHVFFNUFgxRGEwYjhldDlYQURmZw?oc=5","date":"2024-07-31","type":"deal","source":"PR Newswire","summary":"IDEAYA Biosciences Announces Option and License Agreement for Potential First-in-Class B7H3/PTK7 Topo-I-Payload Bispecific ADC Program with Biocytogen - PR Newswire","headline":"IDEAYA Biosciences Announces Option and License Agreement for Potential First-in-Class B7H3/PTK7 Topo-I-Payload Bispecif","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}